{"id":366797,"date":"2019-05-13T08:55:02","date_gmt":"2019-05-13T08:55:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=366797"},"modified":"2019-05-13T08:55:02","modified_gmt":"2019-05-13T08:55:02","slug":"nucleic-acidbased-therapeutics-market-will-record-usd-74198-million-by-2023-applications-developments-regional-analysis-competitive-landscape-with-global-industry-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nucleic-acidbased-therapeutics-market-will-record-usd-74198-million-by-2023-applications-developments-regional-analysis-competitive-landscape-with-global-industry-forecast-to-2023_366797.html","title":{"rendered":"Nucleic Acid-Based Therapeutics Market will Record USD 741.98 million by 2023 | Applications Developments, Regional Analysis, Competitive Landscape With Global Industry Forecast To 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Nucleic Acid-Based Therapeutics Market”<\/div>\n<\/div>\n<\/div>\n
Nucleic acid-based therapeutics are target deficiencies or dysfunctions at the molecular level and are targeted therapies. These are used specifically to target genetic diseases and disorders for which there exists no permanent cure such as thalassemia, sickle cell anemia, hemophilia, cystic fibrosis, diabetes etc.<\/div>\n

The “Nucleic Acid-Based Therapeutics Market<\/strong>” are based on accurate target identification and genetic profiling and the human gene project has formed the backbone of these class of drugs. As such nucleic acid-based medication have one of the most versatile and revolutionary potential.<\/p>\n

Nucleic Acid-Based Therapeutics Market Overview<\/strong><\/p>\n

Nucleic acid-based therapeutics are target deficiencies or dysfunctions at the molecular level and are targeted therapies. These are used specifically to target genetic diseases and disorders for which there exists no permanent cure such as thalassemia, sickle cell anemia, hemophilia, cystic fibrosis, diabetes etc.<\/span><\/p>\n

The global market for Nucleic Acid-based Therapeutics is expected to reach around USD 741.98 million<\/strong> by the end of the forecast period and is expected to grow at a CAGR of ~6.8%.<\/strong><\/p>\n

Get a Free Sample Copy of the Report at https:\/\/www.marketresearchfuture.com\/sample_request\/2978<\/a><\/strong><\/p>\n

Nucleic Acid-Based Therapeutics Market Segmentation:<\/strong><\/p>\n

Global nucleic acid-based therapeutics market has been segmented on the basis of technology which comprises anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers and others.<\/p>\n

On the basis of applications<\/strong>; market is segmented into monogenetic disorders which is further sub segmented into thalassemia, sickle cell anemia, hemophilia, cystic fibrosis etc. and multi-genetic disorders which is sub segmented into cancer, diabetes, neurodegenerative diseases, cardiovascular diseases etc.<\/p>\n

On the basis of end users<\/strong>; market is segmented into hospitals, academic & research institutes..<\/p>\n

Nucleic Acid-Based Therapeutics Market Competitive Analysis:<\/strong> Some of the key players in this market are:<\/p>\n

Wave Life Sciences Ltd.<\/p>\n

Copernicus Therapeutics Inc.<\/p>\n

Imugene<\/p>\n

Caperna<\/p>\n

Phylogica<\/p>\n

Protagonist Therapeutics<\/p>\n

Benitec Biopharma<\/p>\n

EGEN (Expression Genetics)<\/p>\n

Benitec Biopharma<\/p>\n

BioMedica (Oxford BioMedica)<\/p>\n

Transgene and others.<\/p>\n

Get Exclusive Discount on this Report at https:\/\/www.marketresearchfuture.com\/check-discount\/2978<\/a><\/strong><\/p>\n

Regional Analysis:<\/strong><\/p>\n

Globally America is the largest market for nucleic acid-based therapeutics. The presence of strong research base, excellent reimbursement scenario, the good provisions for orphan diseases and drugs and the rapid uptake of new drugs and technology are the prime reasons for this dominance. Europe is the second-largest market for nucleic acid-based therapeutics. The developed markets are likely to maintain their leads due to the nonexistence of regulatory framework in the developing and poor regions of the world such as Asia pacific region and Africa.<\/p>\n

Study Objectives Global Nucleic Acid-based Therapeutics Market:<\/strong><\/p>\n